罗宾可以抑制骨髓瘤的扩散和迁移,通过Slug/Twist信号轴作用
Isabela Santos1, Hélio M T Albuquerque2, Marta Teixeira Pinto3
1LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal.
European journal of pharmacology
|December 6, 2025
概括
罗宾是一种黄类药物,显示出作为骨髓瘤治疗的巨大潜力. 它有效地降低了癌细胞活力和瘤生长,提供了一个有前途的新治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 骨髓瘤是年轻人中最常见的原发性骨癌.
- 目前的治疗方法已经稳定了生存率,需要新的治疗策略.
- 黄类化合物具有抗氧化,抗炎和抗癌的特性.
研究的目的:
- 评估五种不同类型的黄类药物对骨髓瘤的治疗潜力.
- 为了确定针对骨髓瘤细胞系有效的特定黄类药物.
- 研究有前途的黄类药物与常规化疗的协同作用.
主要方法:
- 在体外查五种黄类药物与四种人类骨髓瘤细胞系 (MG-63,Saos-2,HOS,143B).
- 对健康的人类肺纤维细胞 (MRC-5) 的细胞毒性评估,以确定选择性.
- 对罗宾尼丁与多克索鲁比辛对143B细胞活力,迁移和转移相关的基因表达的协同作用的评估.
- 在体内测试罗宾尼丁的疗效,使用小胆膜异种移植模型.
主要成果:
- 罗宾对骨髓瘤细胞具有最高的细胞毒性,对健康纤维细胞的影响最小.
- 罗宾与多克索鲁比协同作用,降低143B细胞活力并抑制细胞迁移.
- 罗宾治疗导致了与转移相关的关键转录因子的下调:c-Jun,Snail,Slug和Twist2.
- 在体内研究证实了罗宾尼丁能够抑制骨髓瘤瘤异种植的生长.
结论:
- 罗宾在骨髓瘤治疗中表现出显著的治疗潜力.
- 罗宾对骨髓瘤细胞具有选择性毒性.
- 罗宾尼丁和多克索鲁比辛的组合可能提供了一个增强的治疗策略.
- 罗宾代表了未来骨髓瘤药物开发的新型候选药物.
相关概念视频
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Hedgehog Signaling Pathway
9.8K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K


